Skip to main content
    N

    Nexgel Inc (NXGL)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.93
    +0.05 (+1.29%)

    Market Cap: $2.08M

    Last updated: Nov 17, 2026 at 10:58 AM ET

    Nexgel Inc (NXGL) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Nexgel (NXGL) trades at 0.2x sales and 0.5x book value. Its P/S of 0.2x is below its 5-year median of 63.4x. Its forward P/E is 1.4x.

    Current Multiples

    Its enterprise value is 1.3x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E1.4x
    Price to sales0.2x
    Price to book0.5x
    EV/EBITDA1.3x
    PEGN/A
    FCF yield-193.6%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S0.2x63.4xN/A
    P/B0.5x42.5xN/A
    Medians of month-end values through Oct 2026: 51 to 59 months (5-year).

    Valuation History

    Over the 5 year ends shown, its P/S ranged from 20.0x in 2025 to 117.9x in 2021. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$32.2020.0x56.7x
    2024$89.2068.3x113.2x
    2023$42.6059.2x52.1x
    2022$25.0068.0x18.3x
    2021$52.20117.9x24.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About NXGL

    What is NXGL's forward P/E ratio?

    Nexgel has a forward P/E ratio of 1.4x.

    What is NXGL's price to sales ratio?

    Nexgel has a price to sales ratio of 0.2x.